Chromatin structural elements and chromosomal translocations in leukemia

DNA Repair

Volumn 5, Issue 9-10, 2006, Pages 1282-1297

  Zhang, Yanming ^a   Rowley, Janet D ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Chromosomal translocations; Leukemia; Non homologous end joining; Topoisomerase II

Indexed keywords

ALKYLATING AGENT; BCR ABL PROTEIN; CORE BINDING FACTOR; DAUNORUBICIN; DEOXYRIBONUCLEASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE INHIBITOR; DOUBLE STRANDED DNA; DOXORUBICIN; EPIPODOPHYLLOTOXIN; ETOPOSIDE; MITOXANTRONE; MIXED LINEAGE LEUKEMIA PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR E2A; TRANSCRIPTION FACTOR RUNX1;

ACUTE GRANULOCYTIC LEUKEMIA; ALU SEQUENCE; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; CHROMATIN STRUCTURE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; DNA CLEAVAGE; DNA SEQUENCE; DNA STRAND BREAKAGE; DNA STRUCTURE; ENZYME DEGRADATION; GENE CLUSTER; GENE DELETION; GENE DUPLICATION; GENE LOCATION; GENE MAPPING; GENETIC ANALYSIS; GENETIC RECOMBINATION; GENOTOXICITY; HUMAN; LEUKEMIA; LYMPHOMA; MALIGNANT TRANSFORMATION; MATRIX ATTACHMENT REGION; MOLECULAR CLONING; MOLECULAR MECHANICS; MYELODYSPLASTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; SARCOMA; SEQUENCE HOMOLOGY;

CHROMATIN; CHROMOSOME BREAKAGE; DEOXYRIBONUCLEASE I; DNA REPAIR; DNA TOPOISOMERASES, TYPE II; HUMANS; INTRONS; LEUKEMIA; LYMPHOMA; MODELS, GENETIC; TRANSLOCATION, GENETIC;

EID: 33747873409     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2006.05.020     Document Type: Article

References (122)

1. Nowell P., and Hungerford D. A minute chromosome in human granulocytic leukemia. Science 132 (1960) 1497
2. Rowley J.D. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243 (1973) 290-293
3. Rabbitts T.H. Chromosomal translocations in human cancer. Nature 372 (1994) 143-149
4. Rowley J.D. The critical role of chromosome translocations in human leukemias. Annu. Rev. Genet. 32 (1998) 495-519
5. Look A.T. Oncogenic transcription factors in the human acute leucemias. Science 278 (1997) 1059-1064
6. Pedersen-Bjergaard J., and Rowley J.D. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 83 (1994) 2780-2786
7. Mitelman F., Johansson B., and Mertens F. Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer. Nat. Genet. 36 (2004) 331-334
8. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). World Health Organization Classification of Tumours, Pathology and Genetics: Tumours of the Hematopoietic and Lymphoid Tissues (2001), IARC, Lyon
9. Tomlins S.A., Rhodes D.R., Perner S., Dhanasekaran S.M., Mehra R., Sun X.W., Varambally S., Cao X., Tchinda J., Kuefer R., Lee C., Montie J.E., Shah R.B., Pienta K.J., Rubin M.A., and Chinnaiyan A.M. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310 (2005) 644-648
10. Grimwade D., Walker H., Oliver F., Wheatley K., Harrison C., Harrison G., Rees J., Hann I., Stevens R., Burnett A., and Goldstone A. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 92 (1998) 2322-2333
11. Druker B.J., Sawyers C.L., Kantarjian H., Resta D.J., Reese S.F., Ford J.M., Capdeville R., and Talpaz M. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N. Engl. J. Med. 344 (2001) 1038-1042
12. Wiemels J.L., Cazzaniga G., Daniotti M., Eden O.B., Addison G.M., Masera G., Saha V., Biondi A., and Greaves M.F. Prenatal origin of acute lymphoblastic leukaemia in children. Lancet 354 (1999) 1499-1503
13. Finger L.R., Harvey R.C., Moore R.C., Showe L.C., and Croce C.M. A common mechanism of chromosomal translocation in T and B cell neoplasia. Science 234 (1986) 982-985
14. Rabbitts T.H., Boehm T., and Mengle-Gaw L. Chromosomal abnormalities in lymphoid tumors: mechanism and role in tumor pathogenesis. Trends Genet. 4 (1988) 300-304
15. Rowley J.D. Chromosome translocations: dangerous liaisons revisited. Nat. Rev. Cancer 1 (2001) 245-250
16. Cools J., DeAngelo D.J., Gotlib J., Stover E.H., Legare R.D., Cortes J., Kutok J., Clark J., Galinsky I., Griffin J.D., Cross N.C., Tefferi A., Malone J., Alam R., Schrier S.L., Schmid J., Rose M., Vandenberghe P., Verhoef G., Boogaerts M., Wlodarska I., Kantarjian H., Marynen P., Coutre S.E., Stone R., and Gilliland D.G. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N. Engl. J. Med. 348 (2003) 1201-1214
17. Golub T.R., Barker G.F., Lovett M., and Gilliland D.G. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77 (1994) 307-316
18. Bousquet M., Quelen C., De Mas V., Duchayne E., Roquefeuil B., Delsol G., Laurent G., Dastugue N., and Brousset P. The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene. Oncogene 24 (2005) 7248-7252
19. Smith S.M., Le Beau M.M., Huo D., Karrison T., Sobecks R.M., Anastasi J., Vardiman J.W., Rowley J.D., and Larson R.A. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood 102 (2003) 43-52
20. Pedersen-Bjergaard J., Andersen M.K., Christiansen D.H., and Nerlov C. Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia. Blood 99 (2002) 1909-1912
21. Pedersen-Bjergaard J. Insights into leukemogenesis from therapy-related leukemia. N. Engl. J. Med. 352 (2005) 1591-1594
22. Rowley J.D., and Olney H.J. International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: overview report. Genes Chrom. Cancer 33 (2002) 331-345
23. Bloomfield C.D., Archer K.J., Mrozek K., Linnington D.M., Kanko Y., Head D.R., Dai Cin P., and Ramondi S.C. 11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chrom. Cancer 33 (2002) 362-378
24. Slovak M.L., Bedell V., Popplewell L., Arber D.A., Schoch C., and Slater R. 21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop. Genes Chrom. Cancer 33 (2002) 379-394
25. Pedersen-Bjergaard J., and Philip P. Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II. Blood 78 (1991) 1147-1148
26. Borrow J., Shearman A.M., Stanton V.P., Becher R., Collins T., Williams A.J., Dube I., Katz F., Kwong Y.L., Morris C., Ohyashiki K., Toyama K., Rowley J.D., and Housman D.E. The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9. Nat. Genet. 12 (1996) 159-167
27. Nakamura T., Largaespada D.A., Lee M.P., Johnson L.A., Ohyashiki K., Toyama K., Chen S.J., Willman C.L., Chen I.M., Feinberg A.P., Jenkins N.A., Copeland N.G., and Shaughnessy J.D. Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nat. Genet. 12 (1996) 154-158
28. Ahuja H.G., Felix C.A., and Aplan P.D. Potential role for DNA topoisomerase II poisons in the generation of t(11;20)(p15;q11) translocations. Genes Chrom. Cancer 29 (2000) 96-105
29. Kobzev Y.N., Martinez-Climent J., Lee S., Chen J., and Rowley J.D. Analysis of translocations that involve the NUP98 gene in patients with 11p15 chromosomal rearrangements. Genes Chrom. Cancer 41 (2004) 339-352
30. Greaves M.F. Infant leukaemia biology, aetiology and treatment. Leukemia 10 (1996) 372-377
31. Martinez-Climente J.A., Thirman M.J., Espinosa III R., Le Beau M.M., and Rowley J.D. Detection of 11q23/MLL rearrangements in infant leukemias with fluorescent in situ hybridization and molecular analysis. Leukemia 9 (1995) 1299-1304
32. Mazo A.M., Huang D.H., Mozer B.A., and Dawid I.B. The trithorax gene, a trans-acting regulator of the bithorax complex in Drosophila, encodes a protein with zinc-binding domains. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 2112-2116
33. Rowley J.D. Identification of a translocation with quinacrine fluorescence in a patient with acute leukemia. Ann. Genet. 16 (1973) 109-112
34. Miyoshi H., Shimizu K., Kozu T., Maseki N., Kaneko Y., and Ohki M. The t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia clustered within a limited region of a novel gene, AML1. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 10431-10434
35. Erickson P., Gao J., Chang K.S., Look T., Whisenant E., Raimondi S., Lasher R., Trujillo J., Rowley J.D., and Drabkin H. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 80 (1992) 1825-1831
36. Speck N.A., and Terryl S. A new transcription factor family associated with human leukemias. Crit. Rev. Eukaryot. Gene Expr. 5 (1995) 337-364
37. Okuda T., van Deursen J., Hiebert S.W., Grosveld G., and Downing J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84 (1996) 321-330
38. Yergeau D.A., Hetherington C.J., Wang Q., Zhang P., Sharpe A.H., Binder M., Marin-Padilla M., Tenen D.G., Speck N.A., and Zhang D.E. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nat. Genet. 15 (1997) 303-306
39. Wang Q., Stacy T., Miller J.D., Lewis A.F., Gu T.L., Huang X., Bushweller J.H., Bories J.C., Alt F.W., Ryan G., Liu P.P., Wynshaw-Boris A., Binder M., Marin-Padilla M., Sharpe A.H., and Speck N.A. The CBF subunit is essential for CBFalpha2 (AML1) function in vivo. Cell 87 (1996) 697-708
40. Le Beau M.M., Larson R.A., Bitter M.A., Vardiman J.W., Golomb H.M., and Rowley J.D. Association of inv(16)(p13q22) with abnormal marrow eosinophils in acute myelomonocytic leukemia: a unique cytogenetic-clinicopathologic association. N. Engl. J. Med. 309 (1983) 630-636
41. Liu P.P., Tarle S.A., Hajra A., Claxton D.F., Marlton P., Freedman M., Siciliano M.J., and Collins F.S. Fusion between transcription factor CBFbeta/PEBP2beta and a myosin heavy chain in acute myeloid leukemia. Science 261 (1993) 1041-1044
42. Castilla L.H., Wijmenga C., Wang Q., Stacy T., Speck N.A., Eckhaus M., Marin-Padilla M., Collins F.S., Wynshaw-Boris A., and Liu P.P. Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell 87 (1996) 687-696
43. de The H., Chomienne C., Lanotte M., Degos L., and Dejean A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347 (1990) 558-561
44. Grimwade D. The pathogenesis of acute promyelocytic leukaemia: evaluation of the role of molecular diagnosis and monitoring in the management of the disease. Br. J. Haematol. 106 (1999) 591-613
45. Huang M.E., Ye Y.C., Chen S.R., Chai J.R., Lu J.X., Zhao L., Gu L.J., and Wang Z.Y. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72 (1988) 567-572
46. Chen S.J., Zelent A., Tong J.H., Yu H.Q., Wang Z.Y., Derre J., Berger R., Waxman S., and Chen Z. Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia. J. Clin. Invest. 91 (1993) 2260-2267
47. Reichel M., Gillert E., Breitenlohner I., Repp R., Greil J., Beck J.D., Fey G.H., and Marschalek R. Rapid isolation of chromosomal breakpoints from patients with t(4;11) acute lymphoblastic leukemia. Cancer Res. 59 (1999) 3357-3362
48. Reichel M., Gillert E., Nilson I., Siegler G., Greil J., Fey G.H., and Marschalek R. Fine structure of translocation breakpoints in leukemic blasts with chromosomal translocation t(4;11): the DNA damage-repair model of translocation. Oncogene 17 (1998) 3035-3044
49. Hensel J.P., Gillert E., Fey G.H., and Marschalek R. Breakpoints of t(4;11) translocations in the human MLL and AF4 genes in ALL patients are preferentially clustered outside of high-affinity matrix attachment regions. J. Cell Biochem. 82 (2001) 299-309
50. Reichel M., Gillert E., Angermuller S., Hensel J.P., Heidel F., Lode M., Leis T., Biondi A., Haas O.A., Strehl S., Panzer-Grumayer E.R., Griesinger F., Beck J.D., Greil J., Fey G.H., Uckun F.M., and Marschalek R. Biased distribution of chromosomal breakpoints involving the MLL gene in infants versus children and adults with t(4;11) ALL. Oncogene 20 (2001) 2900-2907
51. Gillert E., Leis T., Repp R., Reichel M., Hosch A., Breitenlohner I., Angermuller S., Borkhardt A., Harbott J., Lampert F., Griesinger F., Greil J., Fey G.H., and Marschalek R. A DNA damage repair mechanism is involved in the origin of chromosomal translocations t(4;11) in primary leukemic cells. Oncogene 18 (1999) 4663-4671
52. Gill-Super H., Strissel P., Sobulo O.M., Burian D., Reshmi S.C., Roe B., Zeleznik-le N.J., Diaz M.O., and Rowley J.D. Identification of complex genomic breakpoint junction in the t(9;11) MLL-AF9 fusion gene in acute leukemia. Genes Chrom. Cancer 10 (1997) 185-195
53. Atlas M., Head D., Behm F., Schmidt E., Zeleznik-Le N.J., Roe B.A., Burian D., and Domer P.H. Cloning and sequence analysis of four t(9;11) therapy-related leukemia breakpoints. Leukemia 12 (1998) 1895-1902
54. Langer T., Metzler M., Reinhardt D., Viehmann S., Borkhardt A., Reichel M., Stanulla M., Schrappe M., Creutzig U., Ritter J., Leis T., Jacobs U., Harbott J., Beck J.D., Rascher W., and Repp R. Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides. Genes Chrom. Cancer 36 (2003) 393-401
55. Zhang Y., Strissel P., Strick R., Chen J., Nucifora G., Le Beau M.M., Larson R.A., and Rowley J.D. Genomic DNA breakpoints cluster in AML1/RUNX1 and ETO with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 3070-3075
56. Xiao Z., Greaves M.F., Buffler P., Smith M.T., Segal M.R., Dicks B.M., Wiencke J.K., and Wiemels J.L. Molecular characterization of genomic AML 1-ETO fusions in childhood leukemia. Leukemia 15 (2001) 1906-1913
57. van der Reijden B.A., Dauwerse H.G., Giles R.H., Jagmohan-Changur S., Wijmenga C., Liu P.P., Smit B., Wessels H.W., Beverstock G.C., Jotterand-Bellomo M., Martinet D., Muhlematter D., Lafage-Pochitaloff M., Gabert J., Reiffers J., Bilhou-Nabera C., van Ommen G.J., Hagemeijer A., and Breuning M.H. Genomic acute myeloid leukemia-associated inv(16)(p13q22) breakpoints are tightly clustered. Oncogene 18 (1999) 543-550
58. Reiter A., Saussele S., Grimwade D., Wiemels J.L., Segal M.L., Lafage-Pochitaloff M., Walz C., Weisser A., Hochhaus A., Willer A., Reichert A., Buechner T., Lengfelder E., Hehlmann R., and Cross N. Genomic anatomy of the specific reciprocal translocation t(15;17) in acute promyelocytic leukemia. Genes Chrom. Cancer 36 (2003) 175-188
59. Mistry A.R., Felix C.A., Whitmarsh R.J., Mason A., Reiter A., Cassinat B., Parry A., Walz C., Wiemels J.L., Segal M.R., Ades L., Blair I.A., Osheroff N., Peniket A.J., Lafage-Pochitaloff M., Cross N.C., Chomienne C., Solomon E., Fenaux P., and Grimwade D. DNA topoisomerase II in therapy-related acute promyelocytic leukemia. N. Engl. J. Med. 352 (2005) 1529-1538
60. Zhang Y., Zeleznik-Le N.L., Emmanuel N., Jayathilaka N., Chen J., Strissel P., Strick R., Li L., Neilly M.B., Taki T., Hayashi Y., Kaneko Y., Schlegelberger B., and Rowley J.D. Characterization of genomic breakpoints in MLL and CBP in leukemia patients with t(11;16). Genes Chrom. Cancer 41 (2004) 257-265
61. Wiemels J.L., Alexander F.E., Cazzaniga G., Biondi A., Mayer S.P., and Greaves M. Structure and possible mechanisms of TEL-AML1 gene fusions in childhood acute lymphoblastic leukemia. Genes Chrom. Cancer 29 (2000) 219-228
62. Wiemels J.L., and Greaves M. Structure and possible mechanisms of TEL-AML1 gene fusions in childhood acute lymphoblastic leukemia. Cancer Res. 59 (1999) 4075-4082
63. Thandla S.P., Ploski J.E., Raza-Egilmez S.Z., Chhalliyil P.P., Block A.W., de Jong P.J., and Aplan P.D. ETV6-AML1 translocation breakpoints cluster near a purine/pyrimidine repeat region in the ETV6 gene. Blood 93 (1999) 293-299
64. Wiemels J.L., Leonard B.C., Wang Y., Segal M.R., Hunger S.P., Smith M.T., Crouse V., Ma X., Buffler P.A., and Pine S.R. Site-specific translocation and evidence of post-natal origin of the t(1;19) E2A-PBX1 translocation in childhood acute lymphoblastic leukaemia. Proc. Natl. Acad. Sci. U.S.A. 99 (2003) 15101-15106
65. Chen S.J., Chen Z., Font M.P., d'Auriol L., Larsen C.J., and Berger R. Structural alterations of the BCR and ABL genes in Ph1 positive acute leukemias with rearrangements in the BCR gene first intron: further evidence implicating Alu sequences in the chromosome translocation. Nucleic Acid Res. 17 (1989) 7631-7642
66. Chissoe S.L., Bodenteich A., Wang Y.F., Wang Y.P., Burian D., Clifton S.W., Crabtree J., Freeman A., Iyer K., Jian L., Ma Y., McLaury H.J., Pan H.Q., Omayma H., Sarhan T., Steve T., Wang Z., Zhang G., Heisterkamp N., Groffen J., and Roe B.A. Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation. Genomics 27 (1995) 67-82
67. Jeffs A.R., Wells E., and Morris C.M. Nonrandom distribution of interspersed repeat elements in the BCR and ABL1 genes and its relations to breakpoint cluster regions. Genes Chrom. Cancer 92 (2001) 144-154
68. Strissel P.L., Gill-Super H., Thirman M.J., Pomykala H., Yonebayashi Y., Tanabe S., Zeleznik-Le N.J., and Rowley J.D. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites. Blood 87 (1996) 1912-1922
69. Strissel P.L., Strick R., Rowley J.D., and Zeleznik-Le N.J. An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region. Blood 92 (1998) 3793-3803
70. Felix C.A., Lange B.J., Hosler M.R., Fertala J., and Bjornsti M.A. Chromosome band 11q23 translocation breakpoints are DNA topoisomerase II cleavage sites. Cancer Res. 55 (1995) 4287-4292
71. Stanulla M., Wang J., Chervinsky D.S., Thandla S., and Aplan P.D. DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis. Mol. Cell. Biol. 17 (1997) 4070-4079
72. Cimino G., Rapanotti M.C., Biondi A., Elia L., Lo Coco F., Price C., Rossi V., Rivolta A., Canaani E., Croce C.M., Mandelli F., and Greaves M. Infant leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias. Cancer Res. 57 (1997) 2879-2883
73. Blanco J.G., Edick M.J., and Relling M.V. Etoposide induces chimeric MLL gene fusions. FASEB J. 18 (2004) 173-175
74. Shimizu K., Miyoshi H., Kozu T., Nagata J., Enomoto K., Maseki N., Kaneko Y., and Ohki M. Consistent disruption of the AML1 gene occurs within a single intron in the t(8;21) chromosomal translocation. Cancer Res. 52 (1992) 6945-6948
75. Tighe J.E., and Calabi F. t(8;21) breakpoints are clustered between alternatively spliced exons of MTG8. Clin. Sci. (Lond.) 89 (1995) 215-218
76. Nucifora G., and Rowley J.D. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood 86 (1995) 1-14
77. Hirai H., Ogawa S., Kurokawa M., Yazaki Y., and Mitani K. Molecular characterization of the genomic breakpoints in a case of t(3;21)(q26;q22). Genes Chrom. Cancer 26 (1999) 92-96
78. Roulston D., Espinosa R., Nucifora G., Larson R.A., Le Beau M.M., and Rowley J.D. CBFA2(AML1) translocations with novel partner chromosomes in myeloid leukemias: association with prior therapy. Blood 92 (1998) 2879-2885
79. Baens M., Peeters P., Guo C., Aerssens J., and Marynen P. Genomic organization of TEL: the human ETS-variant gene 6. Genome Res. 6 (1996) 404-413
80. Andersen M.K., Johansson B., Larsen S.O., and Pedersen-Bjergaard J. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements. Haematologica 83 (1998) 438-483
81. Rubin C.M., Arthur D.C., Woods W.G., Lange B.J., Nowell P.C., Rowley J.D., Nachman J., Bostrom B., Baum E.S., Suarez C.R., Shah N.R., Morgan E., Maurer H.S., McKenzie S.E., Larson R.A., and Le Beau M.M. Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children: correlation between chromosomal abnormalities and prior therapy. Blood 78 (1991) 2982-2988
82. Strissel P.L., Strick R., Tomek R.J., Roe B., and Zeleznik-Le N.J. AF9, a common partner gene in MLL translocations of leukemia patients, demonstrates similar DNA structural properties to MLL that could act as recombination "hot spots". Hum. Mol. Genet. 9 (2002) 1671-1679
83. Aplan P.D., Chervinsky D.S., Stanulla M., and Burhans W.C. Site-specific DNA jncleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors. Blood 87 (1996) 2649-2658
84. Watt P.M., and Hickson I.D. Structure and function of type II DNA topoisomerases. J. Biochem. 303 (1994) 681-695
85. Durrieu F., Samejima K., Fortune J.M., Kandels-Lewis S., Osheroff N., and Earnshaw W.C. DNA topoisomerase II alpha interacts with CAD nuclease and is involved in chromatin condensation during apoptotic execution. Curr. Biol. 10 (2000) 923-926
86. Mondal N., and Parvin J.D. DNA topoisomerase II alpha is required for RNA polymerase II transcription on chromatin templates. Nature 413 (2001) 435-438
87. Strick R., and Laemmli U.K. SARs are cis elements of chromosome dynamics: synthesis of a SAR repressor protein. Cell 83 (1995) 1137-1148
88. Adachi Y., Luke M., and Laemmli U.K. Chromosome assembly in vitro: topoisomerase II is required for condensation. Cell 64 (1991) 137-148
89. Lovett B.D., Nigro L., Rappaport E.F., Blair I.A., Osheroff N., Zheng N., Megonigal M.D., Williams W.R., Nowell P.C., and Felix C.A. Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 9802-9807
90. Kas E., and Laemmli U.K. In vivo topoisomerase II cleavage of the Drosophila histone and satellite III repeats: DNA sequence and structural characteristics. EMBO J. 11 (1992) 705-716
91. Udvardy A., and Schedl P. Chromatin structure, not DNA sequence specificity, is the primary determinant of topoisomerase II sites of action in vivo. Mol. Cell. Biol. 11 (1991) 4973-4984
92. Borde V., and Duguet M. The mapping of DNA topoisomerase sites in vivo: a tool to enlight the functions of topoisomerases. Biochimie 80 (1998) 223-233
93. Spitzner J.R., and Muller M.T. A consensus sequence for cleavage by vertebrate DNA topoisomerase II. Nucleic Acids Res. 16 (1988) 5533-5556
94. Iarovaia O.V., Shkumatov P., and Razin S.V. Breakpoint cluster regions of the AML-1 and ETO genes contain MAR elements and are preferentially associated with the nuclear matrix in proliferating HEL cells. J. Cell Sci. 117 (2004) 4583-4590
95. Bode J., Benham C., Ernst E., Knopp A., Marschalek R., Strick R., and Strissel P. Fatal connections: when DNA ends meet on the nuclear matrix. J. Cell Biochem. 35 (2002) 3-22
96. Liu L.F. DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem. 58 (1989) 351-375
97. Khan Q.A., Kohlhagen G., Marshall R., Austin C.A., Kalena G.P., Kroth H., Sayer J.M., Jerina D.M., and Pommier Y. Position-specific trapping of topoisom erase II by benzo[a]pyrene diol epoxide adducts: implications for interactions with intercalating anticancer agents. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 12498-12503
98. Reilling M.V., Yanishevski Y., Nemec I., Evans W.E., Boyett J.M., Behm F.G., and Pui C.H. Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia. Leukemia 12 (1998) 346-352
99. Strick R., Zhang Y., Emmanuel N., and Strissel P. Common chromatin structures at breakpoint cluster regions may lead to chromosomal translocations found in chronic and acute leukemias. Hum. Genet. 119 (2006) 479-495
100. Sperry A.O., Blasquez V.C., and Garrard W.T. Dysfunction of chromosomal loop attachment sites: illegitimate recombination linked to matrix association regions and topoisomerase II. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 5497-5501
101. Kowalski D., Natale D.A., and Eddy M.J. Stable DNA unwinding, not "breathing," accounts for single-strand-specific nuclease hypersensitivity of specific A + T-rich sequences. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 9464-9468
102. Huang Y., and Kowalski D. WEB-THERMODYN: sequence analysis software for profiling DNA helical stability. Nucleic Acids Res. 31 (2003) 3819-3821
103. Natale D.A., Schubert A.E., and Kowalski D. DNA helical stability accounts for mutational defects in a yeast replication origin. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 2654-2658
104. Natale D.A., Umek R.M., and Kowalski D. Ease of DNA unwinding is a conserved property of yeast replication origins. Nucleic Acids Res. 21 (1993) 555-560
105. Umek R.M., and Kowalski D. The ease of DNA unwinding as a determinant of initiation at yeast replication origins. Cell 52 (1988) 559-567
106. Roix J.J., McQueen P.G., Munson P.J., Parada L.A., and Misteli T. Spatial proximity of translocation-prone gene loci in human lymphomas. Nature Genet. 34 (2003) 287-291
107. Murmann A.E., Gao J., Encinosa M., Gautier M., Peter M.E., Eils R., Lichter P., and Rowley J.D. Local gene density predicts the spatial position of genetic loci in the interphase nucleus. Exp. Cell Res. 311 (2005) 14-26
108. Neves H., Ramos C., da Silva M.G., Parreira A., and Parreira L. The nuclear topography of ABL, BCR, PML, and RARalpha genes: evidence for gene proximity in specific phases of the cell cycle and stages of hematopoietic differentiation. Blood 93 (1999) 1197-1207
109. Bickmore W.A., and van der Maarel S.M. Perturbations of chromatin structure in human genetic disease: recent advances. Hum. Mol. Genet. 12 (2003) R207-R213
110. Nikiforova M.N., Stringer J.R., Blough R., Medvedovic M., Fagin J.A., and Nikiforov Y.E. Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. Science 290 (2000) 138-141
111. Panagopoulos I., Isaksson M., Lindvall C., Hagemeijer A., Mitelman F., and Johansson B. Genomic characterization of MOZ/CBP and CBP/MOZ chimeras in acute myeloid leukemia suggests the involvement of a damage-repair mechanism in the origin of the t(8;16)(p11;p13). Genes Chrom. Cancer 36 (2003) 90-98
112. Aoki K., Suzuki K., Sugano T., Tasaka T., Nakahara K., Kuge O., Omori A., and Kasai M. A novel gene translin encodes a recombination hotspot binding protein associated with chromosomal translocations. Nature Genet. 10 (1995) 167-174
113. Tycko B., and Sklar J. Chromosomal translocations in lymphoid neoplasia: a reappraisal of the recombinase model. Cancer Cells 2 (1990) 1-8
114. Cheng J.T., Yang C.Y., Hernandez J., Embrey J., and Baer R. The chromosome translocation (11;14)(p13;q11) associated with T cell acute leukemia: asymmetric diversification of the translocational junctions. J. Exp. Med. 171 (1990) 489-501
115. Wyatt R.T., Rudders R.A., Zelenetz A., Delellis R.A., and Krontiris T.G. BCL2 oncogene translocation is mediated by a Chi-like consensus. J. Exp. Med. 175 (1992) 1575-1588
116. Domer P.H., Head D.R., Renganathan N., Raimondi S.C., Yang E., and Atlas M. Molecular analysisof 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11). Leukemia 9 (1995) 1305-1312
117. Schichman S., Caligiuri M., Gu Y., Strout M., Canaani E., Bloomfield C.D., and Croce C.M. ALL-1 partial duplication in acute leukemia. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 6236-6239
118. Strout M.P., Marcucci G., Bloomfield C.D., and Caligiuri M.A. The partial tandem duplication of ALL 1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 2390-2395
119. Zucman-Rossi J., Legoix P., Victor J.M., Lopez B., and Thomas G. Chromosome translocation based on illegitimate recombination in human tumors. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 11786-11791
120. Strick R., Strissel P.L., Borgers S., Smith S.L., and Rowley J.D. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 4790-4795
121. Betti C.J., Villalobos M.J., Diaz M.O., and Vaughan A.T. Apoptotic triggers initiate translocations within the MLL gene involving the nonhomologous end joining repair system. Cancer Res. 61 (2001) 4550-4555
122. Eguchi-Ishimae M., Eguchi M., Ishii E., Miyazaki S., Ueda K., Kamada N., and Mizutani S. Breakage and fusion of the TEL (ETV6) gene in immature B lymphocytes induced by apoptogenic signals. Blood 97 (2001) 737-743